APO Research
Talk to an analyst

APO RESEARCH · REPORT

Six-Ingredient Rehmannia Pill

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Six-Ingredient Rehmannia Pill Market Outlook and Growth Opportunities 2026

27 December 2025191 pages

Choose your research edition.

Industry ResearchSix-Ingredient Rehmannia Pill Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Six-Ingredient Rehmannia Pill Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Six-Ingredient Rehmannia Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Six-Ingredient Rehmannia Pill Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Six-Ingredient Rehmannia Pill Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Six-Ingredient Rehmannia Pill market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Six-Ingredient Rehmannia Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Six-Ingredient Rehmannia Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Six-Ingredient Rehmannia Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Six-Ingredient Rehmannia Pill market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Six-Ingredient Rehmannia Pill market include Changchun Dirui Pharmaceutical Co., Ltd., Xi'an Afang Palace Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Sichuan Everbright Pharmaceutical Co., Ltd., Shaanxi Hanwang Pharmaceutical Co., Ltd., Langzhi Group Wanrong Pharmaceutical Co., Ltd., Jiangxi Puzheng Pharmaceutical Co., Ltd., Jilin Yizheng Pharmaceutical Group Co., Ltd. and Jilin Hengjin Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Six-Ingredient Rehmannia Pill market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Six-Ingredient Rehmannia Pill and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Six-Ingredient Rehmannia Pill sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Six-Ingredient Rehmannia Pill market size, projected growth trends, production technologies, key applications, and end-use industries.

Six-Ingredient Rehmannia Pill Segment by Company

Changchun Dirui Pharmaceutical Co., Ltd.

Xi'an Afang Palace Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Everbright Pharmaceutical Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Langzhi Group Wanrong Pharmaceutical Co., Ltd.

Jiangxi Puzheng Pharmaceutical Co., Ltd.

Jilin Yizheng Pharmaceutical Group Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Heilongjiang Kangmax Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory

Guangdong Zaitian Pharmaceutical Co., Ltd.

Chenxin Pharmaceutical Jilin Co., Ltd.

Six-Ingredient Rehmannia Pill Segment by Type

Bottled

Boxed

Six-Ingredient Rehmannia Pill Segment by Application

Hospital

Clinic

Other

Six-Ingredient Rehmannia Pill Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Six-Ingredient Rehmannia Pill status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Six-Ingredient Rehmannia Pill market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Six-Ingredient Rehmannia Pill significant trends, drivers, influence factors in global and regions.

6. To analyze Six-Ingredient Rehmannia Pill competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Six-Ingredient Rehmannia Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Six-Ingredient Rehmannia Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Six-Ingredient Rehmannia Pill.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Six-Ingredient Rehmannia Pill market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Six-Ingredient Rehmannia Pill industry.

Chapter 3: Detailed analysis of Six-Ingredient Rehmannia Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Six-Ingredient Rehmannia Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Six-Ingredient Rehmannia Pill in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Six-Ingredient Rehmannia Pill Industry Trends Table 2. Six-Ingredient Rehmannia Pill Industry Drivers Table 3. Six-Ingredient Rehmannia Pill Industry Opportunities and Challenges Table 4. Six-Ingredient Rehmannia Pill Industry Restraints Table 5. Global Six-Ingredient Rehmannia Pill Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Six-Ingredient Rehmannia Pill Revenue Share by Company (2021-2026) Table 7. Global Six-Ingredient Rehmannia Pill Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Company (2021-2026) Table 9. Global Six-Ingredient Rehmannia Pill Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Six-Ingredient Rehmannia Pill Company Ranking, (2024-2026) & (USD Million) Table 11. Global Six-Ingredient Rehmannia Pill Key Company Manufacturing Base & Headquarters Table 12. Global Six-Ingredient Rehmannia Pill Company, Product Type & Application Table 13. Global Six-Ingredient Rehmannia Pill Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Six-Ingredient Rehmannia Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bottled Table 18. Significant Companies of Boxed Table 19. Global Six-Ingredient Rehmannia Pill Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Six-Ingredient Rehmannia Pill Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Six-Ingredient Rehmannia Pill Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Type (2021-2026) Table 23. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Type (2027-2032) Table 24. Global Six-Ingredient Rehmannia Pill Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Six-Ingredient Rehmannia Pill Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Six-Ingredient Rehmannia Pill Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Six-Ingredient Rehmannia Pill Sales Value Share by Type (2021-2026) Table 28. Global Six-Ingredient Rehmannia Pill Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Six-Ingredient Rehmannia Pill Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Six-Ingredient Rehmannia Pill Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Six-Ingredient Rehmannia Pill Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Application (2021-2026) Table 36. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Application (2027-2032) Table 37. Global Six-Ingredient Rehmannia Pill Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Six-Ingredient Rehmannia Pill Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Six-Ingredient Rehmannia Pill Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Six-Ingredient Rehmannia Pill Sales Value Share by Application (2021-2026) Table 41. Global Six-Ingredient Rehmannia Pill Sales Value Share by Application (2027-2032) Table 42. Global Six-Ingredient Rehmannia Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Six-Ingredient Rehmannia Pill Sales by Region (2021-2026) & (K Units) Table 44. Global Six-Ingredient Rehmannia Pill Sales Market Share by Region (2021-2026) Table 45. Global Six-Ingredient Rehmannia Pill Sales by Region (2027-2032) & (K Units) Table 46. Global Six-Ingredient Rehmannia Pill Sales Market Share by Region (2027-2032) Table 47. Global Six-Ingredient Rehmannia Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Six-Ingredient Rehmannia Pill Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Six-Ingredient Rehmannia Pill Sales Value Share by Region (2021-2026) Table 50. Global Six-Ingredient Rehmannia Pill Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Six-Ingredient Rehmannia Pill Sales Value Share by Region (2027-2032) Table 52. Global Six-Ingredient Rehmannia Pill Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Six-Ingredient Rehmannia Pill Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Six-Ingredient Rehmannia Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Six-Ingredient Rehmannia Pill Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Six-Ingredient Rehmannia Pill Sales by Country (2021-2026) & (K Units) Table 57. Global Six-Ingredient Rehmannia Pill Sales Market Share by Country (2021-2026) Table 58. Global Six-Ingredient Rehmannia Pill Sales by Country (2027-2032) & (K Units) Table 59. Global Six-Ingredient Rehmannia Pill Sales Market Share by Country (2027-2032) Table 60. Global Six-Ingredient Rehmannia Pill Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Six-Ingredient Rehmannia Pill Sales Value Market Share by Country (2021-2026) Table 62. Global Six-Ingredient Rehmannia Pill Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Six-Ingredient Rehmannia Pill Sales Value Market Share by Country (2027-2032) Table 64. Changchun Dirui Pharmaceutical Co., Ltd. Company Information Table 65. Changchun Dirui Pharmaceutical Co., Ltd. Business Overview Table 66. Changchun Dirui Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Changchun Dirui Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 68. Changchun Dirui Pharmaceutical Co., Ltd. Recent Development Table 69. Xi'an Afang Palace Pharmaceutical Co., Ltd. Company Information Table 70. Xi'an Afang Palace Pharmaceutical Co., Ltd. Business Overview Table 71. Xi'an Afang Palace Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Xi'an Afang Palace Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 73. Xi'an Afang Palace Pharmaceutical Co., Ltd. Recent Development Table 74. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 75. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 76. Sichuan Kelun Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sichuan Kelun Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 78. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development Table 79. Sichuan Everbright Pharmaceutical Co., Ltd. Company Information Table 80. Sichuan Everbright Pharmaceutical Co., Ltd. Business Overview Table 81. Sichuan Everbright Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sichuan Everbright Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 83. Sichuan Everbright Pharmaceutical Co., Ltd. Recent Development Table 84. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 85. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 86. Shaanxi Hanwang Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shaanxi Hanwang Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 88. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development Table 89. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information Table 90. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Business Overview Table 91. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 93. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Development Table 94. Jiangxi Puzheng Pharmaceutical Co., Ltd. Company Information Table 95. Jiangxi Puzheng Pharmaceutical Co., Ltd. Business Overview Table 96. Jiangxi Puzheng Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jiangxi Puzheng Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 98. Jiangxi Puzheng Pharmaceutical Co., Ltd. Recent Development Table 99. Jilin Yizheng Pharmaceutical Group Co., Ltd. Company Information Table 100. Jilin Yizheng Pharmaceutical Group Co., Ltd. Business Overview Table 101. Jilin Yizheng Pharmaceutical Group Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jilin Yizheng Pharmaceutical Group Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 103. Jilin Yizheng Pharmaceutical Group Co., Ltd. Recent Development Table 104. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 105. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 106. Jilin Hengjin Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jilin Hengjin Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 108. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 109. Heilongjiang Kangmax Pharmaceutical Co., Ltd. Company Information Table 110. Heilongjiang Kangmax Pharmaceutical Co., Ltd. Business Overview Table 111. Heilongjiang Kangmax Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Heilongjiang Kangmax Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 113. Heilongjiang Kangmax Pharmaceutical Co., Ltd. Recent Development Table 114. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Company Information Table 115. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview Table 116. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Six-Ingredient Rehmannia Pill Product Portfolio Table 118. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Development Table 119. Guangdong Zaitian Pharmaceutical Co., Ltd. Company Information Table 120. Guangdong Zaitian Pharmaceutical Co., Ltd. Business Overview Table 121. Guangdong Zaitian Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Guangdong Zaitian Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 123. Guangdong Zaitian Pharmaceutical Co., Ltd. Recent Development Table 124. Chenxin Pharmaceutical Jilin Co., Ltd. Company Information Table 125. Chenxin Pharmaceutical Jilin Co., Ltd. Business Overview Table 126. Chenxin Pharmaceutical Jilin Co., Ltd. Six-Ingredient Rehmannia Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Chenxin Pharmaceutical Jilin Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio Table 128. Chenxin Pharmaceutical Jilin Co., Ltd. Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Six-Ingredient Rehmannia Pill Distributors List Table 132. Six-Ingredient Rehmannia Pill Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Six-Ingredient Rehmannia Pill Product Image Figure 2. Global Six-Ingredient Rehmannia Pill Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 4. Global Six-Ingredient Rehmannia Pill Sales (2021-2032) & (K Units) Figure 5. Global Six-Ingredient Rehmannia Pill Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Six-Ingredient Rehmannia Pill Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bottled Image Figure 10. Boxed Image Figure 11. Global Six-Ingredient Rehmannia Pill Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Six-Ingredient Rehmannia Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Type (2021-2032) Figure 14. Global Six-Ingredient Rehmannia Pill Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Six-Ingredient Rehmannia Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Six-Ingredient Rehmannia Pill Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Six-Ingredient Rehmannia Pill Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Six-Ingredient Rehmannia Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Six-Ingredient Rehmannia Pill Sales Volume Share by Application (2021-2032) Figure 23. Global Six-Ingredient Rehmannia Pill Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Six-Ingredient Rehmannia Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Six-Ingredient Rehmannia Pill Sales Value Share by Application (2021-2032) Figure 26. Global Six-Ingredient Rehmannia Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Six-Ingredient Rehmannia Pill Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Six-Ingredient Rehmannia Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Six-Ingredient Rehmannia Pill Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 31. North America Six-Ingredient Rehmannia Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Six-Ingredient Rehmannia Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Six-Ingredient Rehmannia Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 37. South America Six-Ingredient Rehmannia Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Six-Ingredient Rehmannia Pill Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Six-Ingredient Rehmannia Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Six-Ingredient Rehmannia Pill Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Six-Ingredient Rehmannia Pill Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Bottled
  • Boxed
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changchun Dirui Pharmaceutical Co., Ltd.
  • Xi'an Afang Palace Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sichuan Everbright Pharmaceutical Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Langzhi Group Wanrong Pharmaceutical Co., Ltd.
  • Jiangxi Puzheng Pharmaceutical Co., Ltd.
  • Jilin Yizheng Pharmaceutical Group Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Heilongjiang Kangmax Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
  • Guangdong Zaitian Pharmaceutical Co., Ltd.
  • Chenxin Pharmaceutical Jilin Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  4. 1.2.2 Global Six-Ingredient Rehmannia Pill Sales Volume (2021-2032)
  5. 1.2.3 Global Six-Ingredient Rehmannia Pill Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Six-Ingredient Rehmannia Pill Market Dynamics
  1. 2.1 Six-Ingredient Rehmannia Pill Industry Trends
  2. 2.2 Six-Ingredient Rehmannia Pill Industry Drivers
  3. 2.3 Six-Ingredient Rehmannia Pill Industry Opportunities and Challenges
  4. 2.4 Six-Ingredient Rehmannia Pill Industry Restraints
3 Six-Ingredient Rehmannia Pill Market by Company
  1. 3.1 Global Six-Ingredient Rehmannia Pill Company Revenue Ranking in 2025
  2. 3.2 Global Six-Ingredient Rehmannia Pill Revenue by Company (2021-2026)
  3. 3.3 Global Six-Ingredient Rehmannia Pill Sales Volume by Company (2021-2026)
  4. 3.4 Global Six-Ingredient Rehmannia Pill Average Price by Company (2021-2026)
  5. 3.5 Global Six-Ingredient Rehmannia Pill Company Ranking (2024-2026)
  6. 3.6 Global Six-Ingredient Rehmannia Pill Company Manufacturing Base and Headquarters
  7. 3.7 Global Six-Ingredient Rehmannia Pill Company Product Type and Application
  8. 3.8 Global Six-Ingredient Rehmannia Pill Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Six-Ingredient Rehmannia Pill Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Six-Ingredient Rehmannia Pill Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Six-Ingredient Rehmannia Pill Market by Type
  1. 4.1 Six-Ingredient Rehmannia Pill Type Introduction
  2. 4.1.1 Bottled
  3. 4.1.2 Boxed
  4. 4.2 Global Six-Ingredient Rehmannia Pill Sales Volume by Type
  5. 4.2.1 Global Six-Ingredient Rehmannia Pill Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Six-Ingredient Rehmannia Pill Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Six-Ingredient Rehmannia Pill Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Six-Ingredient Rehmannia Pill Sales Value by Type
  9. 4.3.1 Global Six-Ingredient Rehmannia Pill Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Six-Ingredient Rehmannia Pill Sales Value by Type (2021-2032)
  11. 4.3.3 Global Six-Ingredient Rehmannia Pill Sales Value Share by Type (2021-2032)
5 Six-Ingredient Rehmannia Pill Market by Application
  1. 5.1 Six-Ingredient Rehmannia Pill Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Six-Ingredient Rehmannia Pill Sales Volume by Application
  6. 5.2.1 Global Six-Ingredient Rehmannia Pill Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Six-Ingredient Rehmannia Pill Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Six-Ingredient Rehmannia Pill Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Six-Ingredient Rehmannia Pill Sales Value by Application
  10. 5.3.1 Global Six-Ingredient Rehmannia Pill Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Six-Ingredient Rehmannia Pill Sales Value by Application (2021-2032)
  12. 5.3.3 Global Six-Ingredient Rehmannia Pill Sales Value Share by Application (2021-2032)
6 Six-Ingredient Rehmannia Pill Regional Sales and Value Analysis
  1. 6.1 Global Six-Ingredient Rehmannia Pill Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Six-Ingredient Rehmannia Pill Sales by Region (2021-2032)
  3. 6.2.1 Global Six-Ingredient Rehmannia Pill Sales by Region: 2021-2026
  4. 6.2.2 Global Six-Ingredient Rehmannia Pill Sales by Region (2027-2032)
  5. 6.3 Global Six-Ingredient Rehmannia Pill Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Six-Ingredient Rehmannia Pill Sales Value by Region (2021-2032)
  7. 6.4.1 Global Six-Ingredient Rehmannia Pill Sales Value by Region: 2021-2026
  8. 6.4.2 Global Six-Ingredient Rehmannia Pill Sales Value by Region (2027-2032)
  9. 6.5 Global Six-Ingredient Rehmannia Pill Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  12. 6.6.2 North America Six-Ingredient Rehmannia Pill Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  15. 6.7.2 Europe Six-Ingredient Rehmannia Pill Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Six-Ingredient Rehmannia Pill Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  21. 6.9.2 South America Six-Ingredient Rehmannia Pill Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Six-Ingredient Rehmannia Pill Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Six-Ingredient Rehmannia Pill Sales Value Share by Country, 2025 VS 2032
7 Six-Ingredient Rehmannia Pill Country-level Sales and Value Analysis
  1. 7.1 Global Six-Ingredient Rehmannia Pill Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Six-Ingredient Rehmannia Pill Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Six-Ingredient Rehmannia Pill Sales by Country (2021-2032)
  4. 7.3.1 Global Six-Ingredient Rehmannia Pill Sales by Country (2021-2026)
  5. 7.3.2 Global Six-Ingredient Rehmannia Pill Sales by Country (2027-2032)
  6. 7.4 Global Six-Ingredient Rehmannia Pill Sales Value by Country (2021-2032)
  7. 7.4.1 Global Six-Ingredient Rehmannia Pill Sales Value by Country (2021-2026)
  8. 7.4.2 Global Six-Ingredient Rehmannia Pill Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Six-Ingredient Rehmannia Pill Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Six-Ingredient Rehmannia Pill Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Six-Ingredient Rehmannia Pill Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changchun Dirui Pharmaceutical Co., Ltd.
  2. 8.1.1 Changchun Dirui Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Changchun Dirui Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Changchun Dirui Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Changchun Dirui Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  6. 8.1.5 Changchun Dirui Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Xi'an Afang Palace Pharmaceutical Co., Ltd.
  8. 8.2.1 Xi'an Afang Palace Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xi'an Afang Palace Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xi'an Afang Palace Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Afang Palace Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  12. 8.2.5 Xi'an Afang Palace Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Sichuan Kelun Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Kelun Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Kelun Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  18. 8.3.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Sichuan Everbright Pharmaceutical Co., Ltd.
  20. 8.4.1 Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Sichuan Everbright Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Sichuan Everbright Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Everbright Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  24. 8.4.5 Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  26. 8.5.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  30. 8.5.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Langzhi Group Wanrong Pharmaceutical Co., Ltd.
  32. 8.6.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  36. 8.6.5 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Puzheng Pharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Puzheng Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Puzheng Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Puzheng Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Puzheng Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  42. 8.7.5 Jiangxi Puzheng Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jilin Yizheng Pharmaceutical Group Co., Ltd.
  44. 8.8.1 Jilin Yizheng Pharmaceutical Group Co., Ltd. Company Information
  45. 8.8.2 Jilin Yizheng Pharmaceutical Group Co., Ltd. Business Overview
  46. 8.8.3 Jilin Yizheng Pharmaceutical Group Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Yizheng Pharmaceutical Group Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  48. 8.8.5 Jilin Yizheng Pharmaceutical Group Co., Ltd. Recent Developments
  49. 8.9 Jilin Hengjin Pharmaceutical Co., Ltd.
  50. 8.9.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jilin Hengjin Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jilin Hengjin Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  54. 8.9.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Heilongjiang Kangmax Pharmaceutical Co., Ltd.
  56. 8.10.1 Heilongjiang Kangmax Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Heilongjiang Kangmax Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Heilongjiang Kangmax Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Heilongjiang Kangmax Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  60. 8.10.5 Heilongjiang Kangmax Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
  62. 8.11.1 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Company Information
  63. 8.11.2 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview
  64. 8.11.3 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Six-Ingredient Rehmannia Pill Product Portfolio
  66. 8.11.5 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Developments
  67. 8.12 Guangdong Zaitian Pharmaceutical Co., Ltd.
  68. 8.12.1 Guangdong Zaitian Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Guangdong Zaitian Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Guangdong Zaitian Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Guangdong Zaitian Pharmaceutical Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  72. 8.12.5 Guangdong Zaitian Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Chenxin Pharmaceutical Jilin Co., Ltd.
  74. 8.13.1 Chenxin Pharmaceutical Jilin Co., Ltd. Company Information
  75. 8.13.2 Chenxin Pharmaceutical Jilin Co., Ltd. Business Overview
  76. 8.13.3 Chenxin Pharmaceutical Jilin Co., Ltd. Six-Ingredient Rehmannia Pill Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chenxin Pharmaceutical Jilin Co., Ltd. Six-Ingredient Rehmannia Pill Product Portfolio
  78. 8.13.5 Chenxin Pharmaceutical Jilin Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Six-Ingredient Rehmannia Pill Value Chain Analysis
  2. 9.1.1 Six-Ingredient Rehmannia Pill Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Six-Ingredient Rehmannia Pill Sales Mode & Process
  6. 9.2 Six-Ingredient Rehmannia Pill Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Six-Ingredient Rehmannia Pill Distributors
  9. 9.2.3 Six-Ingredient Rehmannia Pill Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst